TSS
CURX

Two Sigma Securities’s Curanex Pharmaceuticals CURX Stock Holding History

Two Sigma Securities’s Portfolio CURX Stock Details CURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,833
Closed -$29K – 2562
2026
Q1 		$29K Buy
+2,833
New +$21.3K ﹤0.01% 1324
2025
Q4 		– Sell
-1,622
Closed -$23.4K – 2179
2025
Q3 		$23.4K Buy
+1,622
New +$147K ﹤0.01% 1111

Other funds holding CURX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Securities's CURX Position: Q2 2026 in Review

Two Sigma Securities sold out of Curanex Pharmaceuticals (CURX) in Q2 2026, closing a stake of 2,833 shares — an estimated $29K sold.

Two Sigma Securities first reported a position in CURX in Q3 2025 and held it in 2 quarters. The position peaked at $29K in Q1 2026. 11 funds tracked by Wall St. Rank hold CURX as of Q2 2026.

  • Two Sigma Securities reported no remaining Curanex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 2,833 Curanex Pharmaceuticals shares in Q2 2026, an estimated $29K.
  • Two Sigma Securities first reported a position in Curanex Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Two Sigma Securities's Curanex Pharmaceuticals position peaked at $29K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.